Background Hyperimmune immunoglobulin (hIVIG) contains polyclonal antibodies, which
can be prepared from large amounts of pooled convalescent plasma or prepared from animal …

Background Convalescent plasma and hyperimmune immunoglobulin may reduce mortality
in patients with viral respiratory diseases, and are being investigated as potential therapies …

Background Monoclonal antibodies (mAbs) are laboratory‐produced molecules derived
from the B cells of an infected host. They are being investigated as a potential therapy for …

Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …

… Dr Estcourt reported receiving grants from the NIHR during the conduct of the study. Dr
Fitzgerald reported receiving grants for PREPARE Network from the European Commission, …

Importance Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …

Background The effectiveness of platelet transfusions to prevent bleeding in patients with
hematologic cancers remains unclear. This trial assessed whether a policy of not giving …

The demand for platelets in England was stable at around 220,000 adult therapeutic doses (ATD)
per year until 2007/8 at which point demand has increased year on year to 275,000 …

Platelet refractoriness can represent a significant clinical problem that complicates the
provision of platelet transfusions, is associated with adverse clinical outcomes and increases …

Obesity is associated with an increased risk of severe Coronavirus Disease 2019 (COVID-19)
infection and mortality. COVID-19 vaccines reduce the risk of serious COVID-19 outcomes; …